Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
Overview
Affiliations
Oxidative stress is characterized by excessive production of reactive oxygen species together with exhausted antioxidant defenses. This constitutes a main pathophysiologic process that is implicated in cardiovascular and renal diseases. In particular, enhanced oxidative stress may lead to low-density lipoprotein accumulation and oxidation, endothelial cell activation, adhesion molecule overexpression, macrophage activation, and foam cell formation, promoting the development and progression of atherosclerosis. The deleterious kidney effects of oxidative stress are numerous, including podocytopathy, mesangial enlargement, renal hypertrophy, tubulointerstitial fibrosis, and glomerulosclerosis. The prominent role of oxidative mechanisms in cardiorenal diseases may be counteracted by recently developed pharmacotherapies such as novel antidiabetic agents and finerenone. These agents have demonstrated significant antioxidant activity in preclinical and clinical studies. Moreover, the use of melatonin as a treatment in this field has been experimentally investigated, with large-scale clinical studies being awaited. Finally, clinical implications and future directions in this field are presented.
Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms.
Wang J, Xue H, He J, Deng L, Tian J, Jiang Y Diabetol Metab Syndr. 2024; 16(1):232.
PMID: 39289758 PMC: 11409712. DOI: 10.1186/s13098-024-01466-x.
Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure.
Reiter R, Sharma R, de Almeida Chuffa L, Simko F, Dominguez-Rodriguez A Life (Basel). 2024; 14(1).
PMID: 38255703 PMC: 10820220. DOI: 10.3390/life14010088.
XBP1 Modulates the Aging Cardiorenal System by Regulating Oxidative Stress.
Zhang J, Zhao Y, Gong N Antioxidants (Basel). 2023; 12(11).
PMID: 38001786 PMC: 10669121. DOI: 10.3390/antiox12111933.
Chen X, Li X, Zhang K, Lian K, Zhang W, Song Y Clin Exp Nephrol. 2023; 28(2):125-135.
PMID: 37847437 DOI: 10.1007/s10157-023-02413-2.
Li W, Li W, Zhang W, Wang H, Yu L, Yang P Stem Cell Res Ther. 2023; 14(1):171.
PMID: 37400902 PMC: 10318673. DOI: 10.1186/s13287-023-03371-y.